Zhejiang Hisoar Pharmaceutical Co Ltd Cash Flow Quality Index
Zhejiang Hisoar Pharmaceutical Co Ltd cash flow quality index. Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Cash Flow Quality Index of 5.37x as of June 2025. Operating cash flow of CN¥26.13 Million exceeds net income of CN¥4.86 Million, indicating high earnings quality where cash backs reported profits. Explore Zhejiang Hisoar Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2022)
Cash flow quality index of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2022. Historical Cash Flow Quality Index for Zhejiang Hisoar Pharmaceutical Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 002099 net asset quality score to measure how much of total assets are equity-financed.
Zhejiang Hisoar Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2003–2022)
Zhejiang Hisoar Pharmaceutical Co Ltd cash flow quality index by year from 2003 to 2022. Year-by-year earnings quality comparison for Zhejiang Hisoar Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002099 cash generation efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.35x | CN¥116.09 Million | CN¥86.08 Million | ▲ +23.7% |
| 2021 | 1.09x | CN¥102.36 Million | CN¥93.87 Million | ▼ -34.7% |
| 2020 | 1.67x | CN¥533.87 Million | CN¥319.70 Million | ▲ +110.2% |
| 2019 | 0.79x | CN¥612.40 Million | CN¥770.78 Million | ▼ -39.3% |
| 2018 | 1.31x | CN¥791.45 Million | CN¥605.00 Million | ▲ +336.2% |
| 2017 | 0.30x | CN¥102.68 Million | CN¥342.36 Million | ▼ -89.3% |
| 2016 | 2.80x | CN¥629.42 Million | CN¥224.56 Million | ▲ +209.0% |
| 2015 | 0.91x | CN¥462.16 Million | CN¥509.50 Million | ▼ -78.9% |
| 2014 | 4.29x | CN¥191.56 Million | CN¥44.66 Million | ▼ -52.0% |
| 2012 | 8.94x | CN¥180.73 Million | CN¥20.22 Million | ▲ +903.9% |
| 2011 | 0.89x | CN¥92.62 Million | CN¥104.04 Million | ▼ -57.7% |
| 2010 | 2.11x | CN¥180.88 Million | CN¥85.87 Million | ▼ -35.0% |
| 2009 | 3.24x | CN¥98.38 Million | CN¥30.38 Million | ▲ +169.7% |
| 2008 | 1.20x | CN¥30.61 Million | CN¥25.49 Million | ▼ -26.2% |
| 2007 | 1.63x | CN¥51.14 Million | CN¥31.44 Million | ▲ +38.7% |
| 2006 | 1.17x | CN¥61.88 Million | CN¥52.78 Million | ▲ +63.7% |
| 2005 | 0.72x | CN¥36.07 Million | CN¥50.36 Million | ▼ -39.6% |
| 2004 | 1.19x | CN¥42.36 Million | CN¥35.70 Million | ▲ +597.4% |
| 2003 | -0.24x | CN¥-5.45 Million | CN¥22.86 Million | — |